Stifel analyst Matthew Smith initiated coverage of Hain Celestial with a Hold rating and $17 price target. While he sees "a compelling growth opportunity" over the long term, Smith thinks the on-trend health and wellness opportunity has yet to be realized with inflation and supply chain disruptions delaying Hain’s growth outlook and believes the current valuation "appropriately balances Hain’s growth opportunity against transitional headwinds," he tells investors.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HAIN:
- Hain Celestial Completes Sale of Westbrae Natural® Brand
- Hain Celestial downgraded to In Line from Outperform at Evercore ISI
- Hain Celestial CEO change should create long-term value, says CL King
- Hain Celestial appoints Wendy Davidson as president, CEO
- Hain Celestial price target raised to $18 from $16 at Mizuho